Abstract
The surgical treatment of Hirschsprung’s disease (HD) is reliant on the accurate tissue diagnosis based on increased acetylcholine esterase enzyme (AChE) activity in frozen rectal biopsy sections demonstrated by histochemical staining techniques. The latter techniques used for ascertaining the presence of AChE mandates the use of inaccessible sophisticated instruments thereby limiting the performance of this technique to urban resource rich settings. This bottleneck translates into delayed treatment for patients who live in suburban, resource limited regions. Given the indispensable nature of the surgical treatment, scope for improving accessibility is restricted to the diagnostic modality of the disease.
In our study, we attempted to quantitatively estimate AChE in homogenized rectal mucosal biopsy samples of paediatric population (n=68) using an in-house modified AChE (mACHE) assay. The assay procedure for homogenization of the tissue was modified to selectively extract the mucosal portion of the rectal mucosal biopsy sample to be used for the assay. The efficiency of specific mucosal extraction was confirmed by the absence of neurotrophic AChE nerve fibres in remnant tissue obtained post homogenization by histochemical AChE staining. The mAChE assay was carried out in a blinded manner and the results were compared with the gold standard histochemical AChE (hAChE) assay.
Samples with activity lesser than 1 × 10-6 mole/min/g wet weight of tissue were diagnosed as Non Hirschsprung’s Disease (NHD) and those above 1 × 10-6 mole/min/g wet weight of tissue were diagnosed as HD. mAChE assay was found to have a specificity, sensitivity of 81.08 % and 92.85%; positive, negative predictive values of 78.78% and 93.75 % respectively. The mAChE assay was able to diagnose three cases which were deemed inconclusive as per hAChE.
The improvised in-house mAChE assay had a mutually exclusive range to differentiate between control and test, thus crediting its use as a diagnostic tool for Hirschsprung’s Disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
UK, SN, GS, MB would like to thank RGUHS Advance Research Grant (17M012) for funding support. NK, SD and SN would also like to thank Tata Centre for Technology and Design (TCTD), IIT Bombay for the funding support.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of St John's Medical College and hospital, Bengaluru gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript